DrugPatentWatch Database Preview
Smithkline Beecham Company Profile
» See Plans and Pricing
What is the competitive landscape for SMITHKLINE BEECHAM, and when can generic versions of SMITHKLINE BEECHAM drugs launch?
SMITHKLINE BEECHAM has five approved drugs.
There are two US patents protecting SMITHKLINE BEECHAM drugs.
There are fifty-one patent family members on SMITHKLINE BEECHAM drugs in seventeen countries.
Summary for Smithkline Beecham
| International Patents: | 51 |
| US Patents: | 2 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Drug Master File Entries: | 2 |
Drugs and US Patents for Smithkline Beecham
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | DISCN | No | No | Get Started for $10 | Get Started for $10 | |||||
| Smithkline Beecham | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-003 | Oct 20, 2006 | AB | RX | Yes | Yes | 7,268,156*PED | Get Started for $10 | Y | Get Started for $10 | ||
| Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-001 | Dec 20, 1990 | DISCN | Yes | No | Get Started for $10 | Get Started for $10 | |||||
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-002 | Sep 14, 1995 | AB | RX | Yes | Yes | Get Started for $10 | Get Started for $10 | ||||
| Smithkline Beecham | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-004 | Oct 20, 2006 | AB | RX | Yes | No | 8,101,209*PED | Get Started for $10 | Y | Get Started for $10 | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Smithkline Beecham
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Smithkline Beecham | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-003 | Oct 20, 2006 | RE40000*PED | Get Started for $10 |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-002 | Sep 14, 1995 | 5,902,821*PED | Get Started for $10 |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | 5,902,821*PED | Get Started for $10 |
| Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-002 | Dec 20, 1990 | 4,466,972 | Get Started for $10 |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-001 | Sep 14, 1995 | 4,503,067*PED | Get Started for $10 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SMITHKLINE BEECHAM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 40 mg | ➤ Subscribe | 2007-12-21 |
| ➤ Subscribe | Oral Solution | 15 mg/mL | ➤ Subscribe | 2008-05-14 |
| ➤ Subscribe | Extended-release Capsules | 10 mg and 20 mg | ➤ Subscribe | 2008-03-18 |
| ➤ Subscribe | Extended-release Capsules | 80 mg | ➤ Subscribe | 2007-11-19 |
International Patents for Smithkline Beecham Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 103288714 | Get Started for $10 |
| Japan | 2007532689 | Get Started for $10 |
| China | 103333099 | Get Started for $10 |
| World Intellectual Property Organization (WIPO) | 2005099671 | Get Started for $10 |
| South Korea | 20100063825 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
